Osaic Holdings
INBX icon

Osaic Holdings’s Inhibrx INBX Stock Holding History

Osaic Holdings’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.71K Buy
70
+2
+3% +$148 ﹤0.01% 6712
2025
Q4 		$5.37K Sell
68
-51
-43% -$3.48K ﹤0.01% 6673
2025
Q3 		$4.01K Buy
119
+35
+42% +$862 ﹤0.01% 6870
2025
Q2 		$1.2K Buy
+84
New +$1.09K ﹤0.01% 7094
2025
Q1 		– Sell
-1,751
Closed -$27K – 7580
2024
Q4 		$27K Buy
1,751
+1,666
+1,960% +$25.4K ﹤0.01% 5129
2024
Q3 		$1.33K Buy
85
+5
+6% +$70 ﹤0.01% 6748
2024
Q2 		$1.13K Buy
+80
New +$1.25K ﹤0.01% 6779

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Osaic Holdings's INBX Position: Q1 2026 in Review

Osaic Holdings increased its Inhibrx (INBX) stake by 2.9% in Q1 2026, buying an estimated $148 and bringing the position to 70 shares worth $4.71K. The position accounts for ﹤0.01% of the portfolio, ranked #6712.

Osaic Holdings first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $27K in Q4 2024. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Osaic Holdings held 70 shares of Inhibrx worth $4.71K as of Q1 2026.
  • Osaic Holdings bought 2 Inhibrx shares in Q1 2026, an estimated $148.
  • Inhibrx made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6712 holding.
  • Osaic Holdings first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Inhibrx position peaked at $27K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.